Nai-Kui Liu Selected Research

Inflammation (Inflammations)

9/2012	Neuroprotection and its molecular mechanism following spinal cord injury.
6/2010	Phospholipase A2 and its molecular mechanism after spinal cord injury.
10/2009	Altered microRNA expression following traumatic spinal cord injury.
6/2008	Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.
4/2006	A novel role of phospholipase A2 in mediating spinal cord secondary injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nai-Kui Liu Research Topics

Disease

20	Spinal Cord Injuries (Spinal Cord Injury) 12/2022 - 04/2006
6	Wounds and Injuries (Trauma) 01/2018 - 06/2008
5	Inflammation (Inflammations) 09/2012 - 04/2006
3	Demyelinating Diseases (Demyelinating Disease) 01/2016 - 04/2006
2	Atrophy 01/2021 - 01/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 05/2011 - 06/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2022
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Stroke (Strokes) 01/2019
1	Spinal Injuries (Spinal Injury) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2011
1	Multiple Trauma (Multiple Injuries) 06/2008
1	Necrosis 04/2006

Drug/Important Bio-Agent (IBA)

7	Phospholipases A2 (Phospholipase A2)IBA 01/2021 - 04/2006
4	Neuroprotective AgentsIBA 01/2021 - 10/2007
3	salicylhydroxamic acid (SHAM)IBA 01/2021 - 08/2012
3	bisperoxovanadiumIBA 01/2019 - 01/2012
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021 - 03/2013
2	TensinsIBA 01/2019 - 01/2012
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019 - 01/2012
2	Testosterone (Sustanon)FDA Link 01/2018 - 08/2012
2	baysilon (polydimethylsiloxane)IBA 01/2018 - 08/2012
2	Phospholipases (Phospholipase)IBA 12/2011 - 06/2008
2	MicroRNAs (MicroRNA)IBA 05/2011 - 10/2009
2	Nonesterified Fatty Acids (NEFA)IBA 06/2010 - 06/2008
2	Secretory Phospholipases A2IBA 11/2009 - 06/2008
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2022
1	Cardiolipins (Cardiolipin)IBA 12/2022
1	arachidonyltrifluoromethaneIBA 01/2021
1	Laminin (Merosin)IBA 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2020
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2020
1	Dihydrotestosterone (Androstanolone)IBA 01/2018
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2018
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 01/2016
1	Acrolein (Aqualin)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 05/2014
1	Arachidonic Acid (Vitamin F)IBA 05/2014
1	Proteins (Proteins, Gene)FDA Link 05/2014
1	Free RadicalsIBA 09/2012
1	Glutamic Acid (Glutamate)FDA Link 09/2012
1	TOR Serine-Threonine KinasesIBA 01/2012
1	Platelet Activating FactorIBA 06/2010
1	EicosanoidsIBA 06/2010
1	Annexin A1IBA 10/2007
1	Actins (F Actin)IBA 12/2006
1	Melitten (Melittin)IBA 04/2006
1	Quinacrine (Mepacrine)IBA 04/2006

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2012
2	Transplantation 02/2015 - 01/2013
2	Injections 09/2007 - 04/2006